No Data
H.C. Wainwright Maintains RAPT Therapeutics(RAPT.US) With Hold Rating
H.C. Wainwright analyst Ram Selvaraju maintains $RAPT Therapeutics(RAPT.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 41.2% and a total average return of 2.9%
RAPT Therapeutics (RAPT) Gets a Hold From H.C. Wainwright
RAPT Therapeutics to Cut 40% of Workforce to Save Cash
Rapt Therapeutics Will Reduce Its Workforce By 47 People, Or Approximately 40% Of Its Existing Headcount, The Company Estimates That It Will Incur Approximately $0.9M In Restructuring Charges-8K
Express News | RAPT Therapeutics - Will Incur About $0.9 Mln in Restructuring Charges in Connection With Workforce Reduction
Express News | RAPT Therapeutics Inc: Will Reduce Its Workforce by 47 People, or Approximately 40% of Company's Existing Headcount
No Data